Keywords: nn, sanofi, sign, gabitril, license, deal, novo

NN & Sanofi Sign Gabitril License Deal

Article | 04 December 1997

Print This

Novo Nordisk has signed a licensing agreement with Sanofi for worldwiderights, except for the Americas and Japan, on its antiepileptic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in